Rofecoxib is a nonsteroidal anti-inflammatory drug that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea.
Formerly marketed by Merck & Co.
under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke.
For more information about the topic Rofecoxib, read the full article at Wikipedia.org, or see the following related articles:
Note: This page refers to an article that is licensed under the GNU Free Documentation License. It uses material from the article Rofecoxib at Wikipedia.org. See the Wikipedia copyright page for more details.
Editor's Note: This article is not intended to provide medical advice, diagnosis or treatment.
Recommend this page on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:

